Surface Oncology to Present at Evercore ISI 2nd Annual HealthCONx Conference
November 26, 2019 08:00 ET
|
Surface Oncology, Inc.
CAMBRIDGE, Mass., Nov. 26, 2019 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...